Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||3.48%||8.04||0.7%||$562.03m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.41%||506.48||2.7%||$449.94m|
|GILD||Gilead Sciences, Inc.||0.62%||66.79||1.0%||$433.53m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.18%||219.76||1.9%||$373.88m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.14%||168.44||2.0%||$372.56m|
|CRSP||CRISPR Therapeutics AG||2.68%||124.93||0.6%||$186.56m|
|NBIX||Neurocrine Biosciences, Inc.||0.91%||97.03||4.9%||$178.13m|
|EXAS||EXACT Sciences Corp.||2.49%||128.75||18.4%||$165.21m|
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.